GL1X · GenesisL1 explorer

MolNFT v1 · #111229 · protein

Crystal structure of the R111K:Y134F:T54V:R132Q:P39Q:R59Y:A32Y:F3Q mutant of human cellular retinoic acid binding protein II with retinal at 1.58 ångström resolution

4YKO · Cellular retinoic acid-binding protein 2: “Crystal structure of the R111K:Y134F:T54V:R132Q:P39Q:R59Y:A32Y:F3Q mutant of human cellular retinoic acid…”. X-ray diffraction, 1 ligand (RET), 4 pockets (best druggability 0.83). MolNFT v1…

PDB
4YKO
Type
protein
Length
274 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cellular retinoic acid-binding protein 2
UniProt
P29373
Ligands
RET
Pockets
4 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCellular retinoic acid-binding protein 2protein13714% helix, 53% strandP29373

Ligands and binding sites

  • RET · Retinal · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12150.830.9530RET
22610.820.9329RET
31960.500.7731empty
4840.320.7416empty

Interfaces

1 interface between chains.

  • A–B · 471 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 cofactor (retinal Schiff base).

Compared structures

  • 4YKO · Crystal structure of the R111K:Y134F:T54V:R132Q:P39Q:R59Y:A32Y:F3Q mutant of human… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.